NCT01493518 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis Status TERMINATED Phase PHASE1
NCT01493505 TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer Status TERMINATED Phase PHASE3
NCT01492465 Single Ascending Dose Trial in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE1
NCT01479179 Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab Status WITHDRAWN Phase PHASE1/PHASE2
NCT01470196 Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT01464931 Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis Status COMPLETED Phase PHASE1
NCT01464034 A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01447147 A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy Status COMPLETED Phase PHASE2
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Status COMPLETED Phase N/A
NCT01444417 Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients Status COMPLETED Phase PHASE3
NCT01440257 A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria Status COMPLETED Phase PHASE2
NCT01439880 Open Label Study of Long Term Evaluation Against LDL-C Trial Status COMPLETED Phase PHASE2
NCT01439867 Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism Status TERMINATED Phase PHASE2
NCT01428154 Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease Status WITHDRAWN Phase PHASE1
NCT01419717 Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer Status COMPLETED Phase PHASE3
NCT01416428 Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT01412957 Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01410500 Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease Status APPROVED_FOR_MARKETING Phase N/A